The Tryten Healthcare Team Continues to Respond to COVID-19 by Announcing the Tryten Screening Assistant
SEATTLE, June 5, 2020 /PRNewswire/ -- "The current phase of responding to the novel virus COVID-19 requires a concerted effort to mitigate community spread this summer and into the fall. The CDC has provided guidance for reopening that includes screening employees, visitors and residents (or patients) as they enter or leave facilities to help avoid unnecessary contact and spread of COVID-19. We are introducing the Tryten Screening Assistant to help capture temperature and facilitate the collection of screening questions," said Dr. Deborah A. Jeffries, Global Director of Healthcare at Tryten.
"COVID-19 has placed many stressors in our lives and created a new set of healthcare challenges. We will continue to do all we can to support efforts to combat the virus and support our healthcare community," said Tony Janzen, CEO of Tryten.
About Tryten
Tryten provides mobile healthcare vehicle solutions for EHR access, Video Remote Interpreting (VRI), Tele-sitting, and Telehealth to improve the patient experience, population health, and reduce the cost of care. Tryten manufactures mobile carts that support video conferencing solutions provided by partners. For over 20 years, Tryten has offered safe solutions to enable value-based care when and where it is most needed.
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...